ISSAQUAH, Wash.--(BUSINESS WIRE)-- Spacelabs Healthcare’s new line of patient monitoring and connectivity solutions – including the just-released AriaTeleTM transmitter, qubeTM and XPREZZONTM patient monitors, and ICS XPREZZTM mobile app for iPad – will be featured at the American Nurses Credentialing Center’s annual meeting that will be held October 10-12 in Los Angeles. Owing to their modern and aesthetically appealing design, this collection of new solutions is aptly known as The Art of Monitoring Portfolio.
“By blending the latest technologies with contemporary design, Spacelabs has succeeded in creating a series of new, high-performance solutions to help improve clinical efficiencies, and thereby improve patient care – while creating a visually pleasing experience for caregiver, patient and family,” said Nicholas Ong, President of Spacelabs Healthcare.
With the launch of the AriaTeleTM digital telemetry transmitter this past June, Spacelabs announced the reinvention of medical telemetry, a nod to their having pioneered medical telemetry in the 1960s by monitoring the vital signs of orbiting astronauts and then introducing this technology to hospitals.
The debut of the qubeTM compact monitor in May was preceded months earlier by the introduction of the XPREZZONTM bedside monitor and ICS XPREZZTM mobile app for iPad.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc. (www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the performance of the Company’s products. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.
Spacelabs Healthcare, Inc.
Mobile: +44 (0)7738 342516
Office: +44 (0)1992 507700
Source: Spacelabs Healthcare, Inc.